CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline SPMA Q1 2026 Earnings Preferred Shares Dip on EPS Miss But Stock Edges Higher MaxLinear Inc Q1 2026 Earnings EPS Beats Estimates Amid Unclear Revenue Trends Shift4 Payments FOUR Q1 2026 Earnings Modest EPS Miss Amid Steady Operating Performance Evolus EOLS Q1 2026 Earnings EPS Surprises Positively Despite Stock Decline ACAD Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds